Pricing Log in Create free account

Nasus Pharma Ltd. (NSRX) vs Sanofi (SNY)

Nasus Pharma Ltd. and Sanofi are both Drug Manufacturers General companies. Sanofi is the larger, with a market value of $96.0B against $37.1M — 2591.2× the size. Across the 9 metrics below, Sanofi leads on 6 and Nasus Pharma Ltd. on 3.

Valuation

Metric NSRX SNY Drug Manufacturers General median
P/E — 21.26 24.54
P/S — 1.71 3.39
P/B n/m 1.20 5.00
Price to free cash flow n/m 6.68 16.55
EV/EBITDA n/m 11.07 13.82
EV/Sales n/m 2.02 4.03
Earnings yield — 4.70% 2.98%
Free cash flow yield 0.00% 14.96% 4.46%

Profitability

Metric NSRX SNY Drug Manufacturers General median
Gross margin — 72.78% 72.77%
Operating margin — 18.24% 18.77%
Net margin — 8.22% 8.27%
Free cash flow margin 0.00% 25.53% 17.18%
Return on equity 0.00% 5.87% 5.87%
Return on assets 0.00% 3.21% 2.57%
Return on invested capital 0.00% 6.58% 6.11%

Growth

Metric NSRX SNY Drug Manufacturers General median
Revenue growth (TTM) — 21.30% 6.66%
EPS growth (last fiscal year) (231.82%) 45.97% 21.81%
Revenue growth, 5-year CAGR — 4.37% 4.75%
Net income growth, 5-year CAGR — (8.87%) 0.00%

Health

Metric NSRX SNY Drug Manufacturers General median
Debt to equity 0.00 0.31 0.63
Current ratio 8.77 0.99 1.32
Net debt to EBITDA 0.26 0.76 1.15

Dividend

Metric NSRX SNY Drug Manufacturers General median
Dividend yield — 5.97% 2.33%
Payout ratio — 1.27 0.59

Size

Metric NSRX SNY Drug Manufacturers General median
Market cap 37.06m 96.03b 123.73b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack